Lexicon Pharmaceuticals, Inc.LXRXNASDAQ
Loading
Debt to Assets Over TimeNormalizing
Percentile Rank64
3Y CAGR+5.7%
5Y CAGR+39.9%
Studio
Year-over-Year Change

Debt-to-assets ratio

3Y CAGR
+5.7%/yr
vs -24.2%/yr prior
5Y CAGR
+39.9%/yr
Recent deceleration
Acceleration
+29.9pp
Accelerating
Percentile
P64
Within normal range
vs 5Y Ago
5.4x
Strong expansion
Streak
2 yr
Consecutive declineNormalizing
PeriodValueYoY Change
20250.34-7.4%
20240.36-21.4%
20230.46+62.4%
20220.28+1609.6%
20210.02-73.5%
20200.06-89.4%
20190.59-31.5%
20180.86+53.2%
20170.56+163.8%
20160.21-